Loading…
Reported covered position: Tax Counsel, Senate Finance Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMGEN INC · Firm: AMGEN, INC.
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMGEN INC · Firm: AMGEN, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMGEN INC via AMGEN, INC.
2018 · third_quarter · Q3
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
Source: Senate LDA
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMGEN INC · Firm: AMGEN, INC.
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Client: AMGEN INC · Firm: AMGEN, INC.
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 1 Tax Cuts and Jobs Act.
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill Drug vial size issue, S. 3040, FY2017 Labor Health and Human Services and Education Appropriations bill, and S. 2956, FY2017 Agriculture Appropriations bill
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill Drug vial size issue, S. 3040, FY2017 Labor Health and Human Services and Education Appropriations bill, and S. 2956, FY2017 Agriculture Appropriations bill
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill Drug vial size issue, S. 3040, FY2017 Labor Health and Human Services and Education Appropriations bill, and S. 2956, FY2017 Agriculture Appropriations bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: AMGEN INC · Firm: AMGEN, INC.
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill Drug vial size issue, S. 3040, FY2017 Labor Health and Human Services and Education Appropriations bill, and S. 2956, FY2017 Agriculture Appropriations bill
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
International tax issues, including: President's Fiscal Year 2016 Budget Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts Innovation/Patent Box Innovation Promotion Act of 2015 - Discussion Draft Tax Extenders, R&D Tax Credit, S.1946 Tax Relief Extension Act
International tax issues, including: Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts Innovation/Patent Box Innovation Promotion Act of 2015 - Discussion Draft Tax Extenders, R&D Tax Credit, S.1946 Tax Relief Extension Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
International tax issues, including: President's Fiscal Year 2016 Budget Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts S. 981 Invest in Transportation Act Tax Extenders, R&D Tax Credit, no specific bill
Research and experimentation tax incentives and international tax issues, including: Administrations FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness ActHR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness Act HR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act HR 4 Jobs for America Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts H.R. 4438 American Research and Competitiveness Act H.R. 4464 Permanent CFC-Look-Through Act S. 2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act H.R. 4 Jobs for America Act H.R. 5771, The Tax Increase Prevention Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness Act HR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act HR 4 Jobs for America Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts H.R. 4438 American Research and Competitiveness Act H.R. 4464 Permanent CFC-Look-Through Act S. 2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act H.R. 4 Jobs for America Act H.R. 5771, The Tax Increase Prevention Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness Act HR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act HR 4 Jobs for America Act
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts H.R. 4438 American Research and Competitiveness Act H.R. 4464 Permanent CFC-Look-Through Act S. 2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act H.R. 4 Jobs for America Act H.R. 5771, The Tax Increase Prevention Act
Research and experimentation tax incentives and international tax issues, including: Administrations FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness ActHR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act
Research and experimentation tax incentives and international tax issues, including: - Administration's FY 2013 Revenue Proposals - Tax Reform and Deficit Reduction, including House Ways and Means Discussion Draft and S. 2091, the United States Job Creation and International Tax Reform Act of 2012 - S. 3521, the Family and Business Tax Cut Certainty Act of 2012 - H.R. 942, The American Research and Competitiveness Act of 2011
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2013 Revenue Proposals, Tax Reform, including House Ways and Means Discussion Draft and S. 2091, the United States Job Creation and International Tax Reform Act of 2012- S. 3521, the Family and Business Tax Cut Certainty Act of 2012 - H.R. 942, The American Research and Competitiveness Act of 2011
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provsions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers)
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provisions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers) H.R. 942 American Research and Competitiveness Act of 2011 Provisions related to International tax reform
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provisions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers) H.R. 942 American Research and Competitiveness Act of 2011 Provisions related to International tax reform
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provsions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers)
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provisions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers) H.R. 942 American Research and Competitiveness Act of 2011 Provisions related to International tax reform
2018 · second_quarter · Q2
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 H.R. 6142 Reducing Drug Wastage Act of 2018 FDA issues, no specific bill S.3158 Labor, Health and Human Services Appropriations Act (Senate Report 115-289)
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
2018 · first_quarter · Q1
International tax issues, including: H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 Puerto Rico Tax Incentives
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill H.R. 695 Department of Defense Appropriations Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2017 · first_quarter · 1A
International tax issues, including: Tax Reform Puerto Rico Tax Incentives
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
AMGEN INC via AMGEN, INC.
2017 · fourth_quarter · Q4
Biosimilars, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA 340B Protecting Access for the Underserved and Safety-Net Entities (340B PAUSE Act). S. 2042 Reducing Drug Waste Act of 2017 FDA issues, no specific bill
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 1 Tax Cuts and Jobs Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
AMGEN INC via AMGEN, INC.
2017 · third_quarter · Q3
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding discounts on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
International tax issues, including: Tax Reform Puerto Rico Tax Incentives
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
AMGEN INC via AMGEN, INC.
2017 · second_quarter · Q2
International tax issues, including: Tax Reform Puerto Rico Tax Incentives
Biosimilars, no specific bill PDUFA, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA Health Resources and Services Administration (HRSA) policy regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B), no specific bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
AMGEN INC via AMGEN, INC.
2017 · first_quarter · Q1
International tax issues, including: Tax Reform Puerto Rico Tax Incentives
Biosimilars, no specific bill PDUFA, no specific bill Orphan Drugs, no specific bill Prescription drug value issues, no specific bill S. 469 Affordable and Safe Prescription Drug Importation Act H.R. 1245 Affordable and Safe Prescription Drug Importation Act S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018-2026 (importation, non-interference) H.R. 1628 American Health Care Act; repeal/replace ACA
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
AMGEN INC via AMGEN, INC.
2016 · fourth_quarter · Q4
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2016 · third_quarter · Q3
International tax issues, including: Tax Reform Puerto Rico Tax Incentives H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
Biosimilars, no specific bill H.R. 6, 21st Century Cures Act FDA Reform; Senate Innovation for Healthier Americans Initiative (no bill number) H.R. 3678 Orphan Drugs Prescription drug value issues, no specific bill Drug vial size issue, S. 3040, FY2017 Labor Health and Human Services and Education Appropriations bill, and S. 2956, FY2017 Agriculture Appropriations bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2016 · second_quarter · Q2
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2016 · first_quarter · Q1
International tax issues, including: Tax Reform Innovation/Patent Box Puerto Rico Tax Incentives H.R. 1 Tax Reform Act of 2014 H.R. 4900 Puerto Rico Oversight Management and Economic Stability Act (PROMESA)
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2015 · fourth_quarter · Q4
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act Patent Settlements, S. 2019, the Preserve Access to Affordable Generics Act
International tax issues, including: Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts Innovation/Patent Box Innovation Promotion Act of 2015 - Discussion Draft Tax Extenders, R&D Tax Credit, S.1946 Tax Relief Extension Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMGEN INC via AMGEN, INC.
2015 · third_quarter · Q3
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
International tax issues, including: President's Fiscal Year 2016 Budget Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts Innovation/Patent Box Innovation Promotion Act of 2015 - Discussion Draft Tax Extenders, R&D Tax Credit, S.1946 Tax Relief Extension Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2015 · second_quarter · Q2
H.R. 9-Innovation Act S.632-Support Technology and Research for our Nations Growth (STRONG) Patents Act Trans-Pacific Partnership (12 years data exclusivity) S. 1137, the PATENT Act
International tax issues, including: President's Fiscal Year 2016 Budget Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts S. 981 Invest in Transportation Act Tax Extenders, R&D Tax Credit, no specific bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2015 · first_quarter · Q1
International tax issues, including: President's Fiscal Year 2016 Budget Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2014 · fourth_quarter · Q4
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts H.R. 4438 American Research and Competitiveness Act H.R. 4464 Permanent CFC-Look-Through Act S. 2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act H.R. 4 Jobs for America Act H.R. 5771, The Tax Increase Prevention Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2014 · third_quarter · Q3
Research and experimentation tax incentives and international tax issues, including: President's Fiscal Year 2015 Budget, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness Act HR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act HR 4 Jobs for America Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2014 · second_quarter · Q2
Research and experimentation tax incentives and international tax issues, including: Administrations FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts HR 4438 American Research and Competitiveness ActHR 4464 Permanent CFC-Look-Through Act S.2260 Expiring Provisions Improvement, Reform and Efficiency (Expire) Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2014 · first_quarter · Q1
Research and experimentation tax incentives and international tax issues, including: Administrations FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means and Senate Finance Committee Discussion Drafts
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2013 · fourth_quarter · Q4
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means Discussion Draft
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2013 · third_quarter · Q3
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2014 corporate tax proposals, Tax Reform, including House Ways and Means Discussion Draft
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMGEN INC via AMGEN, INC.
2013 · second_quarter · Q2
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2013 Revenue Proposals, Tax Reform, including House Ways and Means Discussion Draft
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2013 · first_quarter · Q1
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2013 Revenue Proposals, Tax Reform, including House Ways and Means Discussion Draft
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
2012 · fourth_quarter · Q4
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2013 Revenue Proposals, Tax Reform, including House Ways and Means Discussion Draft and S. 2091, the United States Job Creation and International Tax Reform Act of 2012- S. 3521, the Family and Business Tax Cut Certainty Act of 2012 - H.R. 942, The American Research and Competitiveness Act of 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
AMGEN INC via AMGEN, INC.
2012 · third_quarter · Q3
Research and experimentation tax incentives and international tax issues, including: - Administration's FY 2013 Revenue Proposals - Tax Reform and Deficit Reduction, including House Ways and Means Discussion Draft and S. 2091, the United States Job Creation and International Tax Reform Act of 2012 - S. 3521, the Family and Business Tax Cut Certainty Act of 2012 - H.R. 942, The American Research and Competitiveness Act of 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
2012 · second_quarter · 2A
Administration's FY 2013 Revenue Proposals Tax Extenders Tax Reform S. 1813 (MAP-21)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2012 · second_quarter · Q2
Administration's FY 2013 Revenue Proposals Tax Extenders Tax Reform S. 1813 (MAP-21) House Ways & Means Committee International Tax Reform Discussion Draft S. 2091, United States Job Creation and International Tax Reform Act of 2012
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via AMGEN, INC.
2012 · first_quarter · Q1
Administration's FY 2013 Revenue Proposals Tax Extenders Tax Reform S. 1813 (MAP-21) S. 2091, the United States Job Creation and International Tax Reform Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
2011 · fourth_quarter · Q4
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provisions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers) H.R. 942 American Research and Competitiveness Act of 2011 Provisions related to International tax reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMGEN INC via AMGEN, INC.
2011 · third_quarter · Q3
H.R. 1834, Freedom to Invest Act of 2011 (repatriation) S. 1671, the American Growth Act of 2011 (repatriation) S.1577, Greater Research Opportunities with Tax Help Act (R&D Tax Credit) Extension of expiring provsions H.R. 2495, Tax Equity and Middle Class Fairness Act of 2011 (returns on intangible transfers)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE